BRIAN WILLIAMS: Open Payments
NPI 1598701914 · PORTERVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$206 in 10 payments from 6 companies in 2025. Trend: 2023 $1,536 · 2024 $1,075 · 2025 $206
Food & beverage: $206
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Astellas Pharma US Inc | 2 | $44 |
| Lilly USA, LLC | 2 | $43 |
| Novo Nordisk Inc | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Amgen Inc. | 1 | $15 |
Products named: REXULTI, Veozah, JARDIANCE, MOUNJARO, FARXIGA, OTEZLA.
Industry payments across CA — which companies pay providers there.
